UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: April 26, 2011
(Date of earliest event reported)
BIO-RAD LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Commission File Number: 1-7928
|
|
|
Delaware |
| 94-1381833 |
(State or other jurisdiction of incorporation or organization) |
| (I.R.S. Employer Identification No.) |
1000 Alfred Nobel Dr.
Hercules, California 94547
(Address of principal executive offices, including zip code)
(510) 724-7000
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 5.07 | Submission of Matters to a Vote of Security Holders. |
Bio-Rad Laboratories, Inc. (the “Company”) held its Annual Meeting of Stockholders on April 26, 2011. The matters voted upon at the meeting and the results of those votes were as follows:
1. Election of Directors. | |||||||
|
|
|
|
|
| ||
| Class of |
|
|
|
| ||
| Common Stock | Votes | Votes | Votes | Broker | ||
| to Elect | For | Withheld | Abstaining | Non-Votes | ||
|
|
|
|
|
| ||
Louis Drapeau | Class A | 16,802,118 | 2,629,194 | - | 1,757,204 | ||
Albert J. Hillman | Class A | 16,729,654 | 2,701,658 | - | 1,757,204 | ||
Dr. Ted W. Love | Class B | 4,824,229 | 30,850 | - | 210,365 | ||
Alice N. Schwartz | Class B | 4,817,557 | 37,522 | - | 210,365 | ||
David Schwartz | Class B | 4,817,557 | 37,522 | - | 210,365 | ||
Norman Schwartz | Class B | 4,818,613 | 36,466 | - | 210,365 | ||
| |||||||
| |||||||
2. Ratification of the selection of Ernst & Young LLP as the Company’s independent auditors for the fiscal year ending December 31, 2011. | |||||||
| |||||||
Votes | Votes | Votes | Broker | ||||
For | Against | Abstaining | Non-Votes | ||||
7,151,437 | 1,495 | 31,364 | - | ||||
|
|
|
| ||||
|
|
|
| ||||
3. Approval of the Bio-Rad Laboratories, Inc. 2011 Employee Stock Purchase Plan. | |||||||
|
|
|
| ||||
Votes | Votes | Votes | Broker | ||||
For | Against | Abstaining | Non-Votes | ||||
6,731,675 | 48,155 | 18,381 | 386,085 | ||||
|
|
|
| ||||
|
|
|
| ||||
|
|
|
| ||||
4. Advisory vote on executive compensation. | |||||||
|
|
|
| ||||
Votes | Votes | Votes | Broker | ||||
For | Against | Abstaining | Non-Votes | ||||
6,716,867 | 77,542 | 3,802 | 386,085 | ||||
|
|
|
| ||||
|
|
|
| ||||
|
|
|
| ||||
5. Advisory vote on the frequency of executive compensation votes. | |||||||
|
|
|
| ||||
Votes | Votes | Votes | Votes | ||||
1 year | 2 years | 3 years | Abstaining | ||||
1,042,159 | 60,901 | 5,690,841 | 4,310 | ||||
|
|
|
| ||||
|
|
|
| ||||
|
|
|
| ||||
In light of these voting results, the Company will include the advisory vote on executive compensation in its proxy materials every 3 years until the next required vote on the frequency of such advisory votes. | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
| |
|
|
|
|
| |
|
|
| BIO-RAD LABORATORIES, INC. | ||
|
|
|
|
| |
Date: | May 2, 2011 |
| By: | /s/ Christine A. Tsingos | |
|
|
|
|
| Christine A. Tsingos |
|
|
|
|
| Vice President, Chief Financial Officer |
|
|
|
|
|
|